Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wall, Nadezhda A ^a,b   Chue, Colin D ^a,b   Edwards, Nicola C ^a,b   Pankhurst, Tanya ^a   Harper, Lorraine ^a,b   Steeds, Richard P ^a,b   Lauder, Sarah ^a   Townend, Jonathan N ^a,b   Moss, Paul ^a   Ferro, Charles J ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTERIAL STIFFNESS; ARTICLE; ASCENDING AORTA; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DESCENDING AORTA; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PULSE WAVE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84874527596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055686     Document Type: Article

References (37)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047.
2. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081.
3. Chue CD, Townend JN, Steeds RP, Ferro CJ, (2010) Arterial stiffness in chronic kidney disease: causes and consequences. Heart 96: 817-823.
4. Edwards NC, Steeds RP, Ferro CJ, Townend JN, (2006) The treatment of coronary artery disease in patients with chronic kidney disease. QJM 99: 723-736.
5. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, et al. (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27: 2588-2605.
6. Cannon MJ, Schmid DS, Hyde TB, (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20: 202-213.
7. Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, et al. (2003) Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 107: 251-257.
8. Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, et al. (2000) A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med 160: 2027-2032.
9. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, et al. (1998) High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 81: 866-868.
10. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, et al. (1992) A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 326: 1182-1186.
11. Potena L, Holweg CT, Chin C, Luikart H, Weisshaar D, et al. (2006) Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation 82: 398-405.
12. Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, et al. (2002) The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 40: 1408-1413.
13. Adler SP, Hur JK, Wang JB, Vetrovec GW, (1998) Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis 177: 209-212.
14. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, et al. (2000) Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection? Stroke 31: 2127-2133.
15. Steptoe A, Halcox J, (2008) Socioeconomic status and cardiovascular disease risk: authors' reply. Heart 94: 1075.
16. Parrinello CM, Sinclair E, Landay AL, Lurain N, Sharrett AR, et al. (2012) Cytomegalovirus IgG antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis.
17. Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN, (2009) Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol 54: 505-512.
18. Groenink M, de Roos A, Mulder BJ, Spaan JA, van der Wall EE, (1998) Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 82: 203-208.
19. Bland JM, Altman DG, (1994) Matching. Bmj 309: 1128.
20. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, et al. (1996) Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94: 922-927.
21. Stassen FR, Vainas T, Bruggeman CA, (2008) Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 60: 85-92.
22. Caposio P, Orloff SL, Streblow DN, (2011) The role of cytomegalovirus in angiogenesis. Virus Res 157: 204-211.
23. Yi L, Lin JY, Gao Y, Feng ZJ, Wang DX, (2008) Detection of human cytomegalovirus in the atherosclerotic cerebral arteries in Han population in China. Acta Virol 52: 99-106.
24. Yi L, Wang DX, Feng ZJ, (2008) Detection of human cytomegalovirus in atherosclerotic carotid arteries in humans. J Formos Med Assoc 107: 774-781.
25. Hertoghs KM, Moerland PD, van Stijn A, Remmerswaal EB, Yong SL, et al. (2010) Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest 120: 4077-4090.
26. Simmonds J, Fenton M, Dewar C, Ellins E, Storry C, et al. (2008) Endothelial dysfunction and cytomegalovirus replication in pediatric heart transplantation. Circulation 117: 2657-2661.
27. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, et al. (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108: 678-683.
28. Khairy P, Rinfret S, Tardif JC, Marchand R, Shapiro S, et al. (2003) Absence of association between infectious agents and endothelial function in healthy young men. Circulation 107: 1966-1971.
29. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, et al. (2005) Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45: 1219-1222.
30. Joly L, Djaballah W, Koehl G, Mandry D, Dolivet G, et al. (2009) Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging 36: 979-985.
31. Gold L, Ayers D, Bertino J, Bock C, Bock A, et al. (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 5: e15004.
32. Haarala A, Kahonen M, Lehtimaki T, Aittoniemi J, Jylhava J, et al. (2012) Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 167: 309-316.
33. Li S, Zhu J, Zhang W, Chen Y, Zhang K, et al. (2011) Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 124: 175-184.
34. Cheng J, Ke Q, Jin Z, Wang H, Kocher O, et al. (2009) Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 5: e1000427.
35. Majesky MW, (2007) Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 27: 1248-1258.
36. Persoons MC, Daemen MJ, van Kleef EM, Grauls GE, Wijers E, et al. (1997) Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. Cardiovasc Res 36: 282-288.
37. Doyle A, Mark PB, Johnston N, Foster J, Connell JM, et al. (2008) Aortic stiffness and diastolic flow abnormalities in end-stage renal disease assessed by magnetic resonance imaging. Nephron Clin Pract 109: c1-8.